Boron Derivatives Inhibit the Proliferation of Breast Cancer Cells and Affect Tumor-Specific T Cell Activity In Vitro by Distinct Mechanisms

Anti-cancer effect of boron derivatives on small-cell lung cancer

(2022) Emre Cebeci et al.   JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY

Therapeutic Effects of Newly Synthesized Boron Compounds (BGM and BGD) on Hepatocellular Carcinoma

(2021) Meliha Koldemir Gündüz et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Differential Response of MDA-MB-231 and MCF-7 Breast Cancer Cells to In Vitro Inhibition with CTLA-4 and PD-1 through Cancer-Immune Cells Modified Interactions

(2021) Kamil Grubczak et al.   Cells

Design and Characterization of an “All-in-One” Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines

(2020) Katharina Zimmermann et al.   Cancers

Effects of boron-containing compounds on immune responses: review and patenting trends

(2019) Karla S. Romero-Aguilar et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review

(2019) Planes-Laine et al.   Cancers

PD‑L1 expression levels on tumor cells affect their immunosuppressive activity

(2019) Yang Zheng et al.   Oncology Letters

Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination

(2019) Yosi Gilad et al.   Scientific Reports

Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens

(2019) Thaweesak Chieochansin et al.   Scientific Reports

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells

(2019) Saleh et al.   Vaccines

The Physiological Role of Boron on Health

(2018) Haseeb Khaliq et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Panduratin A Inhibits Cell Proliferation by Inducing G0/G1 Phase Cell Cycle Arrest and Induces Apoptosis in Breast Cancer Cells

(2018) Qiuming Liu et al.   Biomolecules & Therapeutics

The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1

(2018) Helena J. Janse van Rensburg et al.   CANCER RESEARCH

The importance of boron in biological systems

(2018) Irem Uluisik et al.   JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY

YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma

(2018) Min Hwan Kim et al.   Cancer Immunology Research

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

(2018) S Adams et al.   ANNALS OF ONCOLOGY

Dermoscopy pathology correlation in melanoma

(2017) Teresa Russo et al.   JOURNAL OF DERMATOLOGY

CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells

(2017) Xiaona Mao et al.   Cell Death & Disease

YAP regulates PD-L1 expression in human NSCLC cells

(2017) Jinbai Miao et al.   Oncotarget

Effect of GADD45a on olaquindox-induced apoptosis in human hepatoma G2 cells: Involvement of mitochondrial dysfunction

(2016) Daowen Li et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients

(2016) Miguel Caballero-Baños et al.   EUROPEAN JOURNAL OF CANCER

PD-1/PD-L1 blockage in cancer treatment—from basic research to clinical application

(2016) Masaki Mandai   International Journal of Clinical Oncology

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

(2016) Don S. Dizon et al.   JOURNAL OF CLINICAL ONCOLOGY

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response

(2016) Min Luo et al.   Oncotarget

Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells

(2016) Juan J. Gu et al.   Oncotarget

Reprint of Application of BNCT to the treatment of HER2+ breast cancer recurrences: Research and developments in Argentina

(2015) M.A. Gadan et al.   APPLIED RADIATION AND ISOTOPES

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Disease implications of the Hippo/YAP pathway

(2015) Steven W. Plouffe et al.   TRENDS IN MOLECULAR MEDICINE

Effect of survivin siRNA on biological behaviour of breast cancer MCF7 cells

(2015) Hao Wang et al.   Asian Pacific Journal of Tropical Medicine

The PD-1/PD-Ls pathway and autoimmune diseases

(2014) Suya Dai et al.   CELLULAR IMMUNOLOGY

Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo

(2013) B. H. Xie et al.   Clinical & Translational Oncology

Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth

(2013) Luca Lignitto et al.   Nature Communications

Boron-Containing Compounds as Preventive and Chemotherapeutic Agents for Cancer

(2012) Romulus I. Scorei et al.   Anti-Cancer Agents in Medicinal Chemistry

Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

(2012) FUJIMASA TADA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells

(2012) Chen Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway

(2012) Wanjin Hong et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Cancer immunotherapy

(2012) Masoud H. Manjili et al.   OncoImmunology

The Hippo Signaling Pathway in Development and Cancer

(2010) Duojia Pan   DEVELOPMENTAL CELL

Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28

(2010) Jacalyn Rosenblatt et al.   JOURNAL OF IMMUNOTHERAPY

Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

(2009) Dawang Zhou et al.   CANCER CELL

Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo

(2009) Yu-gang Wu et al.   MEDICAL ONCOLOGY

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma

(2008) A. Palumbo et al.   ANNALS OF ONCOLOGY

Cancer cells survive with survivin

(2008) Hirofumi Yamamoto et al.   CANCER SCIENCE

The TEAD/TEF Family Protein Scalloped Mediates Transcriptional Output of the Hippo Growth-Regulatory Pathway

(2008) Shian Wu et al.   DEVELOPMENTAL CELL

Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cells

(2008) L. Shen et al.   MOLECULAR CANCER THERAPEUTICS